Agenus reported $667K in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US $ 4499M 307M
Agenus AGEN:US $ 667K 438K
Amgen AMGN:US $ 1637M 147M
AstraZeneca AZN:LN 2193M 273M
Bristol Myers Squibb BMY:US $ 2451M 52M
CSL CSL:AU $ 2.2B 67.3M
Dynavax Technologies DVAX:US $ 14.84M 9.78M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Flexion Therapeutics FLXN:US $ 4.98M 1.11M
Gilead Sciences GILD:US $ 1390M 29M
GlaxoSmithKline GSK:LN 2519M 108M
Glaxosmithkline GSK:US $ 2519M 108M
Intrexon XON:US $ 15.03M 2.06M
Jiangsu Hengrui Me. 600276:CH CH 843.82M 66.58M
Johnson & Johnson JNJ:US $ 7567M 531M
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
MacroGenics MGNX:US 22K 5K
Merck MRK:GR € 1813M 92M
Merk MRK:US $ 2684M 771M
Novartis NOVN:VX SF 3754M 79M
Pfizer PFE:US $ 6992M 2820M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Rigel Pharmaceuticals RIGL:US $ 0.13M 0.19M
Veracyte VCYT:US $ 17.47M 5.07M
YTE INCY:US $ 32.63M 8.81M